𝔖 Bobbio Scriptorium
✦   LIBER   ✦

2.304 Neuropathology of conditional alpha-synuclein transgenic mouse models of Parkinson's disease

✍ Scribed by S. Nuber; E. Petrasch-Parwez; B. Winner; J. Winkler; S. von Hörsten; P. Teismann; J.B. Schulz; M. Neumann; M. Fendt; F.N. Gellerich; O. Riess

Book ID
117752943
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
58 KB
Volume
13
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine receptor agonists reverse behav
Dopamine receptor agonists reverse behavioral abnormalities of α-synuclein transgenic mouse, a new model of Parkinson's disease
✍ Masaki Wakamatsu; Shingo Iwata; Takeo Funakoshi; Makoto Yoshimoto 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

## Abstract Parkinson's disease (PD) is characterized by loss of nigral dopaminergic (DAergic) neurons and presence of Lewy bodies, whose major component is α‐synuclein. We had previously generated transgenic mice termed __Syn130m__ that express truncated human α‐synuclein (amino acid residues 1–13

MRI assessment of neuropathology in a tr
MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease
✍ Joseph A. Helpern; Sang-Pil Lee; Maria F. Falangola; Victor V. Dyakin; Adam Boga 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract The cerebral deposition of amyloid β‐peptide, a central event in Alzheimer's disease (AD) pathogenesis, begins several years before the onset of clinical symptoms. Noninvasive detection of AD pathology at this initial stage would facilitate intervention and enhance treatment success. In